Brief: Epigenomics Successfully Raises EUR 22.3 Mln In Capital Increase
24/10/2018 05:45
Oct 24 (Reuters) - Epigenomics AG ECXn.DE :
* SAID ON MONDAY EPIGENOMICS AG SUCCESSFULLY COMPLETES CAPITAL INCREASE; GROSS PROCEEDS OF
EUR
22.3 MILLION
* COMPANY'S SHARE CAPITAL WILL BE INCREASED FROM CURRENTLY EUR 24,014,360 TO EUR 36,021,540
BY
12,007,180 NEW REGISTERED SHARES OF THE COMPANY AGAINST CONTRIBUTION IN CASH AND PARTLY IN KIND
* GROSS PROCEEDS OF THE CAPITAL INCREASE AMOUNT TO EUR 22.33 MILLION, THEREOF EUR 21.25
MILLION IN
CASH
* FURTHERMORE, FINANCIAL LIABILITIES FROM THE REDEMPTION OF A CONVERTIBLE BOND SUBSCRIBED BY
CATHAY FORTUNE INTERNATIONAL COMPANY LIMITED ARE REDUCED BY EUR 1.08 MILLION FROM EUR 7.1
MILLION TO EUR 6.02 MILLION
Source text for Eikon: ID:nEQ2mKKgra
Further company coverage: ECXn.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns